InvestorsHub Logo
Followers 2
Posts 188
Boards Moderated 0
Alias Born 01/09/2019

Re: dcaf7 post# 311

Tuesday, 03/28/2023 11:01:49 AM

Tuesday, March 28, 2023 11:01:49 AM

Post# of 572
In the case of TUSP monotherapy I am not sure there is an "alternative therapy" to compare with. The patients in the expansion arm have exhausted all currently available therapies and have an average of 3-4 months to live. It will be interesting to see guidance from FDA on this.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APTO News